Christopher Y C Louie, MD | |
1619 N Greenwood St, Suit #210, Pueblo, CO 81003-2656 | |
(719) 542-5121 | |
(719) 584-4736 |
Full Name | Christopher Y C Louie |
---|---|
Gender | Male |
Speciality | Urology |
Location | 1619 N Greenwood St, Pueblo, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467435149 | NPI | - | NPPES |
01245042 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 24504 (Colorado) | Primary |
Entity Name | Christopher Y C Louie Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568645174 PECOS PAC ID: 6507756095 Enrollment ID: O20080123000758 |
News Archive
Anadys Pharmaceuticals, Inc. today announced preliminary results from an ongoing Phase II study demonstrating that 73% of hepatitis C patients treated with 200 mg ANA598 twice daily in combination with pegylated interferon and ribavirin (SOC) achieved undetectable levels of virus (<15 IU/mL) at week 12, known as complete Early Virological Response or cEVR.
Researchers at the Israel Institute of Technology have found that children's mattresses may represent a health hazard as they emit some dangerous pollutants at concerning levels overnight.
For families with a child on the autism spectrum, early intervention is the mantra. The earlier their child is diagnosed, the sooner intervention can start, making a tremendous difference in the life of both the child and family.
Umeå University in Sweden is leading a team of researchers across Europe in the development of a coronavirus simulation framework that can support decision makers to experiment and evaluate possible interventions and their combined effects, in a simulated controlled world.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Christopher Y C Louie, MD 1619 N Greenwood St, Suit #210, Pueblo, CO 81003-2656 Ph: (719) 542-5121 | Christopher Y C Louie, MD 1619 N Greenwood St, Suit #210, Pueblo, CO 81003-2656 Ph: (719) 542-5121 |
News Archive
Anadys Pharmaceuticals, Inc. today announced preliminary results from an ongoing Phase II study demonstrating that 73% of hepatitis C patients treated with 200 mg ANA598 twice daily in combination with pegylated interferon and ribavirin (SOC) achieved undetectable levels of virus (<15 IU/mL) at week 12, known as complete Early Virological Response or cEVR.
Researchers at the Israel Institute of Technology have found that children's mattresses may represent a health hazard as they emit some dangerous pollutants at concerning levels overnight.
For families with a child on the autism spectrum, early intervention is the mantra. The earlier their child is diagnosed, the sooner intervention can start, making a tremendous difference in the life of both the child and family.
Umeå University in Sweden is leading a team of researchers across Europe in the development of a coronavirus simulation framework that can support decision makers to experiment and evaluate possible interventions and their combined effects, in a simulated controlled world.
› Verified 1 days ago
Katy Konkle, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3676 Parker Blvd, Ste 280, Pueblo, CO 81008 Phone: 719-595-8505 Fax: 719-595-8509 |